サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1223360

小線源療法の世界市場：製品タイプ別、投与タイプ別、用途別、エンドユーザー別－地域別展望、競合戦略、セグメント予測（～2032年）

Brachytherapy Market Size-By Product, By Dosage Type, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 256 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
小線源療法の世界市場：製品タイプ別、投与タイプ別、用途別、エンドユーザー別－地域別展望、競合戦略、セグメント予測（～2032年）
出版日: 2023年02月09日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 256 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の小線源療法の市場規模は、2032年まで7.33%で成長し、18億4,000万米ドルに達すると予想されています。加速乳房部分照射（APBI）における小線源療法の利用拡大、乳がんの発生率の増加は、市場の成長を促進すると予想されています。

当レポートでは、世界の小線源療法市場について調査分析し、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
    • 二次データ
    • 一次データ
    • SPERの内部データベース
    • KOLの洞察
  • 市場規模の推定
    • トップダウンとボトムアップのアプローチ
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 世界の小線源療法市場へのCOVID-19の影響

第5章 市場変数と展望

  • SWOT分析
    • 強み
    • 弱点
    • 機会
    • 脅威
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 社会的情勢
    • 技術的情勢
    • 環境的情勢
    • 法的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競争企業間の敵対関係
  • ヒートマップ分析

第6章 競合情勢

  • 世界の小線源療法の製造拠点の分布、販売地域、製品タイプ
  • 世界の小線源療法市場の合併と買収、パートナーシップ、製品発売、およびコラボレーション

第7章 世界の小線源療法市場（100万米ドル）（2019年～2032年）：製品別

  • アプリケーターとアフターローダー
  • 電子小線源療法
  • シード

第8章 世界の小線源療法市場（100万米ドル）（2019年～2032年）：投与タイプ別

  • 高線量率（HDR）
  • 低線量率（LDR）

第9章 世界の小線源療法市場（100万米ドル）（2019年～2032年）：用途別

  • 乳がん
  • 婦人科がん
  • 前立腺がん
  • その他

第10章 世界の小線源療法市場（100万米ドル）（2019年～2032年）：エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第11章 世界の小線源療法市場（100万米ドル）（2019年～2032年）：地域別

  • 世界の小線源療法の市場規模と市場シェア（2019年～2025年）：地域別
  • 世界の小線源療法の市場規模と市場シェア（2026年～2032年）：地域別
  • アジア太平洋
    • オーストラリア
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋地域
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • 英国
    • その他の欧州
  • 中東とアフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他の中東
  • 北米
    • カナダ
    • メキシコ
    • 米国
  • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • その他のラテンアメリカ

第12章 企業プロファイル

  • Argon Medical Devices
  • Becton
  • Best Vascular, Inc
  • Carl Zeiss Meditec AG
  • CIVCO MEDICAL SOLUTIONS
  • Dickinson and Company
  • Eckert & Ziegler BEBIG S.A
  • Elekta AB
  • iCAD Inc
  • Isoray Inc
  • Panacea Medical Technology Pvt. Ltd.
  • RadiaDyne
  • SUN NUCLEAR CORPORATION
  • Theragenics Corporation
  • VARIAN MEDICAL SYSTEMS, INC.

第13章 略語一覧

第14章 参照リンク

第15章 結論

第16章 調査範囲

目次
Product Code: HLCA2312

Global Brachytherapy Market Overview

According to SPER Market Research, the Global Brachytherapy Market is estimated to reach USD 1.84 billion by 2032 with a CAGR of 7.33%.

Brachytherapy equipment is recommended over other radiation therapy equipment for cancer therapy because patients treated with this equipment have a low chance of experiencing a future relapse. Image Guided Brachytherapy (IGBT) and Pulse Dose Rate are two other contemporary brachytherapy techniques (PDR). Brachytherapy is currently enabled by programming agreements that enable the providers of medical services to legally provide and schedule brachytherapy for patients. In the previous years, the prostate cancer market was anticipated to dominate and account for the largest income share. Brachytherapy is a viable treatment option for all individuals with confined prostate cancer development, both when used alone and in conjunction with outer bar radiation therapy. The category is being driven by the promising applications of brachytherapy in the treatment of prostate cancer. During the projection period, a significant CAGR is anticipated for the breast cancer brachytherapy application segment. One of the main factors propelling the development of this market is the growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI). Additionally, the growing incidence of breast cancer is anticipated to fuel the growth of this market.

Impact of COVID-19 on the Global Brachytherapy Market

Global healthcare systems have been impacted by the COVID-19 epidemic, and the market for brachytherapy equipment has also been significantly impacted. According to last year study titled "The Impact of COVID-19 on Brachytherapy," Advances in radiation oncology allowed six patients with unfavourable intermediate- and high-risk diseases to elect to receive EBRT followed by a brachytherapy boost, and since elective surgeries had to be postponed within the system due to the pandemic, four patients were treated with brachytherapy instead. The majority of cancer patients were safely treated with just minimal treatment delays and disruptions, despite the difficulties the healthcare system experienced throughout the epidemic. Therefore, they were considerably impacted as a result of the restrictions imposed by COVID-19. However, the need for brachytherapy equipment is anticipated to increase due to the rise in cardiac procedures.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2032

Base year considered 2021

Forecast period 2022-2032

Segments covered By Product, By Dosage Type, By End User, By Application.

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered Argon Medical Devices, Becton, Best Vascular, Carl Zeiss Meditec AG, CIVCO MEDICAL SOLUTIONS, Dickinson and Company, Eckert & Zieglet BEBIG A.G, Elekta AB, iCAD Inc, Isoray Inc, Panacea Medical Technology Pvt. Ltd., RadiaDyne, SUN NUCLEAR CORPORATION, Theragenics Corporation, VARIAN MEDICAL SYSTEMS, Inc.

Global Brachytherapy Market Segmentation:

By Product: Based on the Type, Global Brachytherapy Market is segmented as; (Applicators & Afterloaders, Electronic Brachytherapy, Seeds)

By Dosage: Based on the Dosage, Global Brachytherapy Market is segmented as;(High-Dose Rate (HDR)Brachytherapy, Low-Dose Rate (LDR)Brachytherapy)

By End User: Based on the End User, Global Brachytherapy Market is segmented as; (Hospitals, Specialty Clinics, Others)

By Application: Based on the Application, Global Brachytherapy Market is segmented as; (Breast Cancer, Gynecological Cancer, Prostate Cancer, Others)

By Region: The regions of Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa make up the worldwide market. Due to the significant presence of major international players and the widespread use of cutting-edge brachytherapy technologies by healthcare facilities in the region, North America is anticipated to dominate the market during the forecast period.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Brachytherapy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Competitive Landscape

  • 6.1 Global Brachytherapy Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Brachytherapy Market

7. Global Brachytherapy Market, By Product, 2019-2032 (USD Million)

  • 7.1 Applicators & Afterloaders
  • 7.2 Electronic Brachytherapy
  • 7.3 Seeds

8. Global Brachytherapy Market, By Dosage Type, 2019-2032 (USD Million)

  • 8.1 High-Dose Rate (HDR)Brachytherapy
  • 8.2 Low-Dose Rate (LDR)Brachytherapy

9. Global Brachytherapy Market, By Application, 2019-2032 (USD Million)

  • 9.1 Breast Cancer
  • 9.2 Gynecological Cancer
  • 9.3 Prostate Cancer
  • 9.4 Others

10. Global Brachytherapy Market, By End-User, 2019-2032 (USD Million)

  • 10.1 Hospitals
  • 10.2 Specialty Clinics
  • 10.3 Others

11. Global Brachytherapy Market, By Region, 2019-2032 (USD Million)

  • 11.1 Global Brachytherapy Market Size and Market Share by Region (2019-2025)
  • 11.2 Global Brachytherapy Market Size and Market Share by Region (2026-2032)
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Europe
    • 11.4.1 France
    • 11.4.2 Germany
    • 11.4.3 Italy
    • 11.4.4 Spain
    • 11.4.5 United Kingdom
    • 11.4.6 Rest of Europe
  • 11.5 Middle East and Africa
    • 11.5.1 Kingdom of Saudi Arabia
    • 11.5.2 United Arab Emirates
    • 11.5.3 Rest of Middle East & Africa
  • 11.6 North America
    • 11.6.1 Canada
    • 11.6.2 Mexico
    • 11.6.3 United States
  • 11.7 Latin America
    • 11.7.1 Argentina
    • 11.7.2 Brazil
    • 11.7.3 Rest of Latin America

12.Company Profiles

  • 12.1 Argon Medical Devices
    • 12.1.1 Company details
    • 12.1.2 Financial outlook
    • 12.1.3 Product summary
    • 12.1.4 Recent developments
  • 12.2 Becton
    • 12.2.1 Company details
    • 12.2.2 Financial outlook
    • 12.2.3 Product summary
    • 12.2.4 Recent developments
  • 12.3 Best Vascular, Inc
    • 12.3.1 Company details
    • 12.3.2 Financial outlook
    • 12.3.3 Product summary
    • 12.3.4 Recent developments
  • 12.4 Carl Zeiss Meditec AG
    • 12.4.1 Company details
    • 12.4.2 Financial outlook
    • 12.4.3 Product summary
    • 12.4.4 Recent developments
  • 12.5 CIVCO MEDICAL SOLUTIONS
    • 12.5.1 Company details
    • 12.5.2 Financial outlook
    • 12.5.3 Product summary
    • 12.5.4 Recent developments
  • 12.6 Dickinson and Company
    • 12.6.1 Company details
    • 12.6.2 Financial outlook
    • 12.6.3 Product summary
    • 12.6.4 Recent developments
  • 12.7 Eckert & Ziegler BEBIG S.A
    • 12.7.1 Company details
    • 12.7.2 Financial outlook
    • 12.7.3 Product summary
    • 12.7.4 Recent developments
  • 12.8 Elekta AB.
    • 12.8.1 Company details
    • 12.8.2 Financial outlook
    • 12.8.3 Product summary
    • 12.8.4 Recent developments
  • 12.9 iCAD Inc
    • 12.9.1 Company details
    • 12.9.2 Financial outlook
    • 12.9.3 Product summary
    • 12.9.4 Recent developments
  • 12.10 Isoray Inc
    • 12.10.1 Company details
    • 12.10.2 Financial outlook
    • 12.10.3 Product summary
    • 12.10.4 Recent developments
  • 12.11 Panacea Medical Technology Pvt. Ltd.
    • 12.11.1 Company details
    • 12.11.2 Financial outlook
    • 12.11.3 Product summary
    • 12.11.4 Recent developments
  • 12.12 RadiaDyne
    • 12.12.1 Company details
    • 12.12.2 Financial outlook
    • 12.12.3 Product summary
    • 12.12.4 Recent developments
  • 12.13 SUN NUCLEAR CORPORATION
    • 12.13.1 Company details
    • 12.13.2 Financial outlook
    • 12.13.3 Product summary
    • 12.13.4 Recent developments
  • 12.14 Theragenics Corporation
    • 12.14.1 Company details
    • 12.14.2 Financial outlook
    • 12.14.3 Product summary
    • 12.14.4 Recent developments
  • 12.15 VARIAN MEDICAL SYSTEMS, INC.
    • 12.15.1 Company details
    • 12.15.2 Financial outlook
    • 12.15.3 Product summary
    • 12.15.4 Recent developments

13.List of Abbreviations

14.Reference Links

15.Conclusion

16.Research Scope